Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.
Yongchao ZhaoJingjing HuXiaolei SunKun YangLebing YangLingqiu KongBeijian ZhangFuhai LiChaofu LiBei ShiKai HuAijun SunJun-Bo GePublished in: Clinical and translational medicine (2022)
We demonstrate that ALKBH5 is a negative regulator of post-ischemic angiogenesis via post-transcriptional modulation and destabilization of WNT5A mRNA in an m6A-dependent manner. Targeting ALKBH5 may be a potential therapeutic option for ischemic diseases, including peripheral artery disease.